GB0401398D0 - New theraputic use - Google Patents

New theraputic use

Info

Publication number
GB0401398D0
GB0401398D0 GBGB0401398.3A GB0401398A GB0401398D0 GB 0401398 D0 GB0401398 D0 GB 0401398D0 GB 0401398 A GB0401398 A GB 0401398A GB 0401398 D0 GB0401398 D0 GB 0401398D0
Authority
GB
United Kingdom
Prior art keywords
new
theraputic
theraputic use
new theraputic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0401398.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arachnova Therapeutics Ltd
Original Assignee
Arachnova Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arachnova Therapeutics Ltd filed Critical Arachnova Therapeutics Ltd
Priority to GBGB0401398.3A priority Critical patent/GB0401398D0/en
Publication of GB0401398D0 publication Critical patent/GB0401398D0/en
Priority to PCT/GB2005/000217 priority patent/WO2005070433A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
GBGB0401398.3A 2004-01-22 2004-01-22 New theraputic use Ceased GB0401398D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0401398.3A GB0401398D0 (en) 2004-01-22 2004-01-22 New theraputic use
PCT/GB2005/000217 WO2005070433A1 (en) 2004-01-22 2005-01-21 Use of pentoxifylline for the prevention or treatment of ulcers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0401398.3A GB0401398D0 (en) 2004-01-22 2004-01-22 New theraputic use

Publications (1)

Publication Number Publication Date
GB0401398D0 true GB0401398D0 (en) 2004-02-25

Family

ID=31971283

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0401398.3A Ceased GB0401398D0 (en) 2004-01-22 2004-01-22 New theraputic use

Country Status (2)

Country Link
GB (1) GB0401398D0 (en)
WO (1) WO2005070433A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090163509A1 (en) * 2006-10-27 2009-06-25 Kopacki Matthew H Method for healing a wound using an alpha-adrenergic antagonist
US20090170857A1 (en) * 2006-10-27 2009-07-02 Kopacki Matthew H Method for healing a wound using a direct vasodilator
US10143694B2 (en) 2006-10-27 2018-12-04 Matthew H. Kopacki Advanced formulations and therapies for treating hard-to-heal wounds
US20090163504A1 (en) * 2006-10-27 2009-06-25 Kopacki Matthew H Method for healing a wound using a phosphodiesterase type five inhibitor
US10772813B2 (en) * 2016-06-03 2020-09-15 Colradel, LLC Compositions and methods of administering a colchicine based topical composition for the prevention of radiation fibrosis
WO2020185674A1 (en) * 2019-03-08 2020-09-17 South Dakota Board Of Regents A vasoactive topical compound to affect tissue blood flow, reduce tissue necrosis and promote healing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Compositions for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivative
JPH09255547A (en) * 1996-03-22 1997-09-30 Kao Corp Skin preparation for external use
WO1997035557A1 (en) * 1996-03-22 1997-10-02 Kao Corporation External skin-care composition
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
GB2333041A (en) * 1998-01-13 1999-07-14 Johnson & Johnson Medical Ltd Wound Composition
US6902721B1 (en) * 1998-07-10 2005-06-07 Osteoscreen, Inc. Inhibitors of proteasomal activity for stimulating bone growth
US20030148955A1 (en) * 1999-04-19 2003-08-07 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
US6204270B1 (en) * 1999-11-12 2001-03-20 Eyal S. Ron Ophthalmic and mucosal preparations
US20020122800A1 (en) * 2000-12-05 2002-09-05 Sonis Stephen T. Treatment of inflammatory oral diseases with a combination of inhibitors of TNF-alpha and immunosuppressive agents
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds

Also Published As

Publication number Publication date
WO2005070433A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
ZA200701820B (en) Substituted phenylaminothiazoles and use thereof
IL177155A0 (en) Therapeutic combinations
GB0418540D0 (en) Use
EP1781302A4 (en) New use
GB0401398D0 (en) New theraputic use
GB0501655D0 (en) Therapeutic use
GB0407301D0 (en) Use
GB0410015D0 (en) Use
GB0412878D0 (en) Use
GB0424494D0 (en) Use
GB0415178D0 (en) New use
GB0427723D0 (en) Compounds and their use
GB0413974D0 (en) Use
GB0405908D0 (en) Use
GB0404201D0 (en) Use
GB0408524D0 (en) Use
GB0418539D0 (en) Use
GB0425061D0 (en) Use
IL164525A0 (en) Use
GB0413973D0 (en) Use
GB0414091D0 (en) Use
GB0405907D0 (en) Use
GB0404200D0 (en) Use
GB0421533D0 (en) Therapeutic use
GB0410395D0 (en) Novel use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)